Analyst Ratings for Rigel Pharmaceuticals (RIGL) [Buys]
RIGL Rating Summary
RIGL Price Target Summary
- Highest: $21.00 (Jefferies)
- Lowest: $6.00 (Wells Fargo)
- Average: $12.13
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$12.13 (+155.8%)
Avg. $ Target:
$12.13 (+155.8%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/6/2012 | Roth Capital | New Coverage | Buy (N/A) |
15.00 (N/A) |
9.89 | 4.74 | -52.07% | Details |
| 9/6/2012 | Leerink Swann | New Coverage | Outperform (N/A) |
16.00 (N/A) |
9.89 | 4.74 | -52.07% | Details |
| 9/29/2011 | JPMorgan | New Coverage | Overweight (N/A) |
14.00 (N/A) |
6.97 | 4.74 | -31.99% | Details |
